Stay updated on NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.

Latest updates to the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the previous entry v3.4.1 was removed.SummaryDifference0.0%

- Check20 days agoChange DetectedThe study record history shows an addition of Revision: v3.4.1 and a deletion of Revision: v3.4.0, indicating a minor system/version update. It does not modify study details or user-facing content.SummaryDifference0.0%

- Check27 days agoChange DetectedThe record history page now includes a glossary toggle and color-coded change highlights (green for additions, red for deletions). The revision label was updated to v3.4.0 and the No FEAR Act Data entry was added, replacing the previous No FEAR Act data and v3.3.4 label.SummaryDifference0.4%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision numbers in the page footer were updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.